Value Research Stocks

Laurus Labs Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

37 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 2005

Chairman: Malempati Venugopala Rao

Managing Director: --

Group: --

Listing: NSE: LAURUSLABS, BSE: 540222

Headquarters: Vishakhapatnam, Andhra Pradesh

Website: www.lauruslabs.com

Key Facts

Market cap: R 4,312.93 Cr

Revenue (TTM): R 2,427.61 Cr

Earnings (TTM): R 132.64 Cr

Cash: R 3.02 Cr

Total Debt: R 1,035.93 Cr

Promoters' ownership: 32.58%

Liquidity: High

52 Week range: R 303.30 - 418.80

Face value: R10.00

Shares outstanding: 10,69,14,499

Stock Performance

Trailing
Annual

Time Period	Laurus Labs	S&P BSE Healthcare	S&P BSE Small Cap
YTD	12.38	4.29	6.95
1 month	6.00	4.54	9.41
3 months	27.86	10.85	11.62
1 Year	6.65	1.18	1.73
3 Years	-5.48	-1.91	4.71
5 Years	--	-1.60	5.10
10 Years	--	11.02	5.27

As on 21-Jan-2020

Year	Laurus Labs	S&P BSE Small Cap	S&P BSE Healthcare
2019	-6.06	-6.85	-3.55
2018	-29.95	-23.41	-5.89
2017	12.90	59.64	0.49

Annual Report (FY18)

Review & Analysis

Companies falling short of cash
Rajan Gulati . 16-May-2019

News & Announcements